Literature DB >> 24574722

Incidence trends and predictors for cost and average lengths of stay in colorectal cancer surgery.

Daw-Shyong Perng1, I-Cheng Lu1, Hon-Yi Shi1, Chih-Wen Lin1, Kuang-Wen Liu1, Ya-Fen Su1, King-Teh Lee1.   

Abstract

AIM: To evaluate the changing trends and outcomes of colorectal cancer (CRC) surgery performed at a large single institution in Taiwan.
METHODS: This study retrospectively analyzed 778 patients who received colorectal cancer surgery at E-Da Hospital in Taiwan from 2004 to 2009. These patients were from health examination, inpatient or emergency settings. The following attributes were analyzed in patients who had undergone CRC surgical procedures: gender, age, source, surgical type, tumor number, tumor size, number of lymph node metastasis, pathologic differentiation, chemotherapy, distant metastases, tumor site, tumor stage, average hospitalization cost and average lengths of stay (ALOS). The odds ratio and 95% confidence intervals were calculated to assess the relative rate of change. Regression models were employed to predict average hospitalization cost and ALOS.
RESULTS: The study sample included 458 (58.87%) males and 320 (41.13%) females with a mean age of 64.53 years (standard deviation, 12.33 years; range, 28-86 years). The principal patient source came from inpatient and emergency room (96.02%). The principal tumor sites were noted at the sigmoid colon (35.73%) and rectum (30.46%). Most patients exhibited a tumor stage of 2 (37.28%) or 3 (34.19%). The number of new CRC surgeries performed per 100000 persons was 12.21 in 2004 and gradually increased to 17.89 in 2009, representing a change of 46.52%. During the same period, the average hospitalization cost and ALOS decreased from $5303 to $4062 and from 19.7 to 14.4 d, respectively. The following factors were associated with considerably decreased hospital resource utilization: age, source, surgical type, tumor size, tumor site, and tumor stage.
CONCLUSION: These results can be generalized to patient populations elsewhere in Taiwan and to other countries with similar patient profiles.

Entities:  

Keywords:  Average hospitalization cost; Average lengths of stay; Colorectal cancer; Colorectal cancer surgery; Incidence trend

Mesh:

Year:  2014        PMID: 24574722      PMCID: PMC3923028          DOI: 10.3748/wjg.v20.i2.532

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  26 in total

1.  Care after colonic operation--is it evidence-based? Results from a multinational survey in Europe and the United States.

Authors:  Henrik Kehlet; Markus W Büchler; Robert W Beart; Richard P Billingham; Russell Williamson
Journal:  J Am Coll Surg       Date:  2005-10-20       Impact factor: 6.113

2.  Nonelective excisional colorectal surgery in English National Health Service Trusts: a study of outcomes from Hospital Episode Statistics Data between 1996 and 2007.

Authors:  Omar Faiz; Janindra Warusavitarne; Alex Bottle; Paris P Tekkis; Sue K Clark; Ara W Darzi; Paul Aylin
Journal:  J Am Coll Surg       Date:  2010-04       Impact factor: 6.113

Review 3.  Cost-effectiveness analysis of colorectal cancer treatments.

Authors:  W B van den Hout; M van den Brink; A M Stiggelbout; C J H van de Velde; J Kievit
Journal:  Eur J Cancer       Date:  2002-05       Impact factor: 9.162

4.  Cancer statistics, 2008.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Taylor Murray; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2008-02-20       Impact factor: 508.702

5.  Estimates of the cancer incidence and mortality in Europe in 2006.

Authors:  J Ferlay; P Autier; M Boniol; M Heanue; M Colombet; P Boyle
Journal:  Ann Oncol       Date:  2007-02-07       Impact factor: 32.976

6.  Colorectal cancer surgery in elderly patients: presentation, treatment, and outcomes.

Authors:  K M Devon; O Vergara-Fernandez; J C Victor; R S McLeod
Journal:  Dis Colon Rectum       Date:  2009-07       Impact factor: 4.585

7.  Changes on the disease pattern of primary colorectal cancers in Southern China: a retrospective study of 20 years.

Authors:  Shenghong Zhang; Yi Cui; Zijin Weng; Xiaorong Gong; Minhu Chen; Bihui Zhong
Journal:  Int J Colorectal Dis       Date:  2009-05-08       Impact factor: 2.571

8.  Evaluation of novel histone deacetylase inhibitors as therapeutic agents for colorectal adenocarcinomas compared to established regimens with the histoculture drug response assay.

Authors:  Jin C Kim; Dae D Kim; Yoo M Lee; Tae W Kim; Dong H Cho; Moon B Kim; Seong G Ro; Seon Y Kim; Yong S Kim; Jung S Lee
Journal:  Int J Colorectal Dis       Date:  2008-10-01       Impact factor: 2.571

9.  Differences among the elderly in the treatment costs of colorectal cancer: how important is race?

Authors:  George E Wright; William E Barlow; Pamela Green; Laura-Mae Baldwin; Stephen H Taplin
Journal:  Med Care       Date:  2007-05       Impact factor: 2.983

10.  Recovery of immunological homeostasis positively correlates both with early stages of right-colorectal cancer and laparoscopic surgery.

Authors:  Mario Ferri; Simone Rossi Del Monte; Gerardo Salerno; Tommaso Bocchetti; Stefano Angeletti; Florence Malisan; Patrizia Cardelli; Vincenzo Ziparo; Maria Rosaria Torrisi; Vincenzo Visco
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

View more
  6 in total

1.  Enhanced recovery after surgery in colon and rectal surgery: identification of predictive variables of failure in a monocentric series including 733 patients.

Authors:  Andrea Vignali; Ugo Elmore; Giovanni Guarneri; Valentino De Ruvo; Paolo Parise; Riccardo Rosati
Journal:  Updates Surg       Date:  2020-07-08

2.  Is ERAS in laparoscopic surgery for colorectal cancer changing risk factors for delayed recovery?

Authors:  Michał Pędziwiatr; Magdalena Pisarska; Michał Kisielewski; Maciej Matłok; Piotr Major; Mateusz Wierdak; Andrzej Budzyński; Olle Ljungqvist
Journal:  Med Oncol       Date:  2016-02-12       Impact factor: 3.064

3.  Musashi-1 promotes a cancer stem cell lineage and chemoresistance in colorectal cancer cells.

Authors:  Guang-Yuh Chiou; Tzu-Wei Yang; Chi-Chou Huang; Chia-Ying Tang; Jung-Yi Yen; Ming-Chang Tsai; Hsuan-Yi Chen; Nurul Fadhilah; Chun-Che Lin; Yuh-Jyh Jong
Journal:  Sci Rep       Date:  2017-05-19       Impact factor: 4.379

4.  Treatment Outcomes of Patients With Colorectal Cancer Enrolled in a Comprehensive Benefits Program of the National Insurance System in the Philippines: Data From the Pilot Site.

Authors:  Frederic Ivan L Ting; Danielle Benedict L Sacdalan; Mayou Martin T Tampo; Rosielyn T Apellido; Hermogenes J Monroy; Marie Dione P Sacdalan; Dennis L Sacdalan
Journal:  JCO Glob Oncol       Date:  2020-02

5.  Hospitalizations and length of stay of cancer patients: A cohort study in the Brazilian Public Health System.

Authors:  Flávia Feliciana Silva; Gisele Macedo da Silva Bonfante; Ilka Afonso Reis; Hugo André da Rocha; Agner Pereira Lana; Mariangela Leal Cherchiglia
Journal:  PLoS One       Date:  2020-05-20       Impact factor: 3.240

6.  Enhanced Recovery After Surgery (ERAS®) protocol in patients undergoing laparoscopic resection for stage IV colorectal cancer.

Authors:  Michał Pędziwiatr; Magdalena Pisarska; Michał Kisielewski; Piotr Major; Maciej Matłok; Mateusz Wierdak; Michał Natkaniec; Andrzej Budzyński
Journal:  World J Surg Oncol       Date:  2015-12-04       Impact factor: 2.754

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.